The global single cell multiomics market size reached USD 4.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 16.6 Billion by 2033, exhibiting a growth rate (CAGR) of 14.6% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 4.6 Billion |
Market Forecast in 2033
|
USD 16.6 Billion |
Market Growth Rate 2025-2033 | 14.6% |
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomics market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type, product type, technique, application and end user.
Breakup by Type:
Breakup by Product Type:
Breakup by Technique:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, Product Type, Technique, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global single cell multiomics market was valued at USD 4.6 Billion in 2024.
We expect the global single cell multiomics market to exhibit a CAGR of 14.6% during 2025-2033.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of single-cell multiomics analysis for early diagnosis of the coronavirus infection among population.
The increasing demand of single cell multiomics for personalized medicine and solutions for screening and diagnosing genetic disorders and cell heterogeneity in the micro-environment, is primarily driving the global single cell multiomics market.
Based on the type, the global single cell multiomics market can be segmented into single cell genomics, single cell proteomics, single cell transcriptomics, and single cell metabolomics. Currently, single cell genomics hold the majority of the total market share.
Based on the product type, the global single cell multiomics market has been divided into consumables, instruments, and software. Among these, consumables currently exhibit a clear dominance in the market.
Based on the technique, the global single cell multiomics market can be categorized into single-cell isolation and dispensing and single-cell analysis. Currently, single-cell isolation and dispensing holds the largest market share.
Based on the application, the global single cell multiomics market has been segregated into oncology, cell biology, neurology, and others, where oncology currently exhibits a clear dominance in the market.
Based on the end user, the global single cell multiomics market can be bifurcated into academic institutes, contract research organizations, and pharmaceutical and biotech companies. Currently, academic institutes account for the majority of the global market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global single cell multiomics market include 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings), and Thermo Fisher Scientific Inc.